To evaluate the link between ILCs and clinicobiological data we focused our analysis on 74 patients for which ILC frequencies and tumor-specific Th1 immunity (focusing on hTERT as a universal tumor-antigen) were available. The gene discussed is CCL27; the disease is neoplasm.